resveratrol has been researched along with Carcinoma in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (50.00) | 29.6817 |
2010's | 10 (45.45) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Ahmad, M; Alharbi, H; Alshehri, AS; Guo, WW | 1 |
Chen, L; Liao, W; Xiong, Y; Yang, S | 1 |
Choi, HE; Choi, JH; Kim, JY; Lee, HH; Lee, KT; Lee, YS; Shin, DH; Shin, JS | 1 |
Abdalla, MOA; Fujiwara, S; Iwase, H; Maehara, K; Matsumori, H; Nakao, M; Ohkawa, Y; Saitoh, N; Tomita, S | 1 |
Hoekstra, A; Rodriguez, GC | 1 |
Bai, YX; Li, HH; Pan, CE; Quan, F; Yao, XB; Yu, L; Zhang, SQ | 1 |
Chen, CC; Huang, TT; Lai, HC; Lin, HC; Liu, FG; Lu, CC; Wei, CF; Wu, TS | 1 |
Chang, YL; Chen, WS; Chen, YW; Chow, SE; Chu, WK; Chuang, SF; Wang, JS | 1 |
Beseler, C; Cavalieri, EL; Rogan, EG; Saeed, M; Zahid, M | 1 |
Bobrov, N; Bojková, B; Ekmekcioglu, C; Garajová, M; Jäger, W; Kassayová, M; Kisková, T; Orendáš, P; Thalhammer, T | 1 |
Huo, WQ; Jin, FS; Lin, X; Wu, G; Zhang, Y | 1 |
Zhang, M; Zhou, K; Zhou, X | 1 |
Ermakova, SP; Vishchuk, OS; Zvyagintseva, TN | 1 |
Köhler, H; Mahyar-Roemer, M; Roemer, K | 1 |
Sun, YN; Yan, Y; Zhou, HB; Zhu, JR | 1 |
Choi, YH; Kim, YA; Park, KY; Rhee, SH | 1 |
Athias, A; Delmas, D; Gambert, P; Grazide, S; Latruffe, N; Laurent, G; Micheau, O; Rébé, C; Solary, E | 1 |
Ahmad, N; Aziz, MH; Fu, VX; Jarrard, DF; Nihal, M | 1 |
Asselin, E; LeBlanc, K; Lemoine, P; Parent, S; Sexton, E; Van Themsche, C | 1 |
Brown, J; Le, AD; Nishitani, J; Shi, S; Tang, X; Zhang, Q | 1 |
Huang, YY; Mehta, RG; Torres, K; Whyte, L | 1 |
Bullock, BP; Narayanan, BA; Narayanan, NK; Stoner, GD | 1 |
22 other study(ies) available for resveratrol and Carcinoma
Article | Year |
---|---|
Promising anti- cervical carcinoma and inflammatory agent, Resveratrol targets poly (ADP-ribose) polymerase 1 (PARP-1) induced premature ovarian failure with a potent enzymatic modulatory activity.
Topics: Animals; Anti-Mullerian Hormone; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Models, Animal; Female; High-Throughput Screening Assays; Humans; Molecular Docking Simulation; Ovarian Follicle; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Primary Ovarian Insufficiency; Rats; Resveratrol; Uterine Cervical Neoplasms; Whole-Body Irradiation | 2021 |
Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model.
Topics: Animals; Carcinoma; Cell Line, Tumor; Fas Ligand Protein; Humans; Immunologic Factors; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-6; Kidney Neoplasms; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Resveratrol; Stilbenes; T-Lymphocytes, Regulatory; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2015 |
Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
Topics: Ataxia Telangiectasia Mutated Proteins; Carcinoma; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Division; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; DNA Damage; Female; G2 Phase; HeLa Cells; Humans; Phosphorylation; Protein Kinases; Quinazolines; Resveratrol; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53; Up-Regulation; Uterine Cervical Neoplasms | 2015 |
A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.
Topics: Adaptation, Physiological; Base Sequence; Breast Neoplasms; Carcinoma; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; In Situ Hybridization, Fluorescence; MCF-7 Cells; Molecular Sequence Data; Resveratrol; RNA, Untranslated; Stilbenes | 2015 |
Chemoprevention of ovarian cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Carcinoma; Chemoprevention; Chickens; Disease Models, Animal; Drug Delivery Systems; Fatty Acids, Omega-3; Female; Humans; Mice; Neoplasm Proteins; Ovarian Neoplasms; Phytoestrogens; Progestins; Resveratrol; Retinoids; Stilbenes; Vitamin D | 2009 |
[Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia].
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Down-Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Multidrug Resistance-Associated Proteins; Nasopharyngeal Neoplasms; Paclitaxel; Resveratrol; Stilbenes | 2009 |
Resveratrol induces apoptosis of human nasopharyngeal carcinoma cells via activation of multiple apoptotic pathways.
Topics: Apoptosis; Carcinoma; Caspases; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Chaperone BiP; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Membrane Potential, Mitochondrial; Models, Biological; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes; Transcription Factor CHOP | 2011 |
Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Nasopharyngeal Neoplasms; Resveratrol; RNA, Small Interfering; Stilbenes; Trans-Activators; Transcription Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |
Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.
Topics: Acetylcysteine; Anticarcinogenic Agents; Breast Neoplasms; Carcinoma; Cell Line; Cell Transformation, Neoplastic; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Mammary Glands, Human; Models, Biological; Resveratrol; Stilbenes | 2011 |
A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Topics: Algorithms; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Carcinoma; Chemoprevention; Drug Evaluation, Preclinical; Estrogen Receptor alpha; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A | 2012 |
Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Membrane Potential, Mitochondrial; Mice; Reactive Oxygen Species; Resveratrol; Stilbenes; Urinary Bladder Neoplasms | 2012 |
Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclins; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2013 |
The effect of sulfated (1→3)-α-l-fucan from the brown alga Saccharina cichorioides Miyabe on resveratrol-induced apoptosis in colon carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Caspases; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; Phaeophyceae; Polysaccharides; Resveratrol; Stilbenes; Sulfuric Acid Esters | 2013 |
Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Survival; Colorectal Neoplasms; Humans; Membrane Potentials; Mitochondria; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2002 |
Resveratrol induces apoptosis in human esophageal carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Esophageal Neoplasms; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2003 |
Antiproliferative effect of resveratrol in human prostate carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Caspases; Cell Division; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2003 |
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carcinoma; Caspases; Cell Line, Tumor; Colonic Neoplasms; fas Receptor; Flow Cytometry; Humans; Ligands; Lipid Metabolism; Lipids; Membrane Glycoproteins; Membrane Microdomains; Mitochondria; Nystatin; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Resveratrol; Signal Transduction; Stilbenes; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2004 |
Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Humans; Male; Microscopy, Fluorescence; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Endometrial Neoplasms; Female; HeLa Cells; Humans; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Uterine Neoplasms | 2006 |
Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
Topics: Anticarcinogenic Agents; Carcinoma; Chromones; Female; Flavonoids; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Neovascularization, Pathologic; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Phosphoinositide-3 Kinase Inhibitors; Repressor Proteins; Resveratrol; RNA, Small Interfering; Stilbenes; Transcriptional Activation; Transfection; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2007 |
Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses.
Topics: Anticarcinogenic Agents; Carcinoma; Cell Cycle; Cell Division; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2007 |
Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants.
Topics: Anticarcinogenic Agents; Antioxidants; Carcinoma; DNA, Neoplasm; Ellagic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Phenols; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2002 |